Back Modlin, IM, Kidd, M, Marks, et al (1997), 'The pivotal role of John S
It works similarly to semaglutide, which is sold under the brand names Ozempic, for diabetes, and Wegovy, for weight loss
Studies in lab settings suggest that GLP-1 receptor agonists can protect brain health by lowering inflammation, boosting mitochondrial function, and improving neuronal communication
For instance, improved food discipline and reduced addictive behaviors have been linked to Ozempic use, potentially due to the medications influence on appetite and satiety
This interaction is particularly critical during the first four weeks of treatment and after each dose increase